CN Patent

CN102811719A — 施用吡非尼酮疗法的方法

Assigned to Intermune Inc · Expires 2012-12-05 · 13y expired

What this patent protects

本发明关于一种涉及避免与吡非尼酮和氟伏沙明或CYP酶的其它中效至强效抑制剂的不良药物相互作用的方法。

USPTO Abstract

本发明关于一种涉及避免与吡非尼酮和氟伏沙明或CYP酶的其它中效至强效抑制剂的不良药物相互作用的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN102811719A
Jurisdiction: CN
Classification: —
Expires: 2012-12-05
Drug substance claim: No
Drug product claim: No
Assignee: Intermune Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.